Litcius/Paper detail

Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II study

Tiandong Kong, Lu Chen, Xiaoli Zhao, Fangfang Duan, Hanli Zhou, Lei Wang, Danna Liu

2022Investigational New Drugs19 citationsDOI

Topics & Concepts

MedicineInternal medicineCarboplatinEtoposideNeutropeniaChemotherapyLung cancerClinical endpointLeukopeniaOncologyNauseaAdverse effectGastroenterologyFebrile neutropeniaPhases of clinical researchSurgeryCisplatinClinical trialLung Cancer Research StudiesNeuroendocrine Tumor Research AdvancesNeutropenia and Cancer Infections
Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II study | Litcius